Literature DB >> 19335659

Emerging role of supervised injecting facilities in human immunodeficiency virus prevention.

M-J Milloy1, Evan Wood.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19335659     DOI： 10.1111/j.1360-0443.2009.02541.x

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  17 in total

Review 1.  Toward a comprehensive approach to HIV prevention for people who use drugs.

Authors:  Brandon D L Marshall; Evan Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

Review 2.  Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review.

Authors:  Mary Clare Kennedy; Mohammad Karamouzian; Thomas Kerr
Journal:  Curr HIV/AIDS Rep       Date:  2017-10       Impact factor: 5.071

3.  Commentary on Enns et al. (2016): Supervised injection facilities as a cost-effective intervention.

Authors:  Nadia Fairbairn; Evan Wood
Journal:  Addiction       Date:  2016-03       Impact factor: 6.526

4.  Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis.

Authors:  Mary Clare Kennedy; Kanna Hayashi; M-J Milloy; Miranda Compton; Thomas Kerr
Journal:  Addiction       Date:  2021-12-02       Impact factor: 6.526

5.  The use of knowledge translation and legal proceedings to support evidence-based drug policy in Canada: opportunities and ongoing challenges.

Authors:  Kora Debeck; Thomas Kerr
Journal:  Open Med       Date:  2010-09-21

6.  Association between public injecting and drug-related harm among HIV-positive people who use injection drugs in a Canadian setting: A longitudinal analysis.

Authors:  Sarah Ickowicz; Evan Wood; Huiru Dong; Paul Nguyen; Will Small; Thomas Kerr; Julio S G Montaner; M-J Milloy
Journal:  Drug Alcohol Depend       Date:  2017-08-10       Impact factor: 4.492

7.  Global patterns of opioid use and dependence: harms to populations, interventions, and future action.

Authors:  Louisa Degenhardt; Jason Grebely; Jack Stone; Matthew Hickman; Peter Vickerman; Brandon D L Marshall; Julie Bruneau; Frederick L Altice; Graeme Henderson; Afarin Rahimi-Movaghar; Sarah Larney
Journal:  Lancet       Date:  2019-10-23       Impact factor: 79.321

Review 8.  Public health and international drug policy.

Authors:  Joanne Csete; Adeeba Kamarulzaman; Michel Kazatchkine; Frederick Altice; Marek Balicki; Julia Buxton; Javier Cepeda; Megan Comfort; Eric Goosby; João Goulão; Carl Hart; Thomas Kerr; Alejandro Madrazo Lajous; Stephen Lewis; Natasha Martin; Daniel Mejía; Adriana Camacho; David Mathieson; Isidore Obot; Adeolu Ogunrombi; Susan Sherman; Jack Stone; Nandini Vallath; Peter Vickerman; Tomáš Zábranský; Chris Beyrer
Journal:  Lancet       Date:  2016-03-24       Impact factor: 79.321

Review 9.  Responding to global stimulant use: challenges and opportunities.

Authors:  Michael Farrell; Natasha K Martin; Emily Stockings; Annick Bórquez; Javier A Cepeda; Louisa Degenhardt; Robert Ali; Lucy Thi Tran; Jürgen Rehm; Marta Torrens; Steve Shoptaw; Rebecca McKetin
Journal:  Lancet       Date:  2019-10-23       Impact factor: 79.321

10.  High willingness to use overdose prevention sites among female sex workers in Baltimore, Maryland.

Authors:  Saba Rouhani; Rebecca Hamilton White; Ju Nyeong Park; Susan G Sherman
Journal:  Drug Alcohol Depend       Date:  2020-05-11       Impact factor: 4.852
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.